Hikma launches TYZAVAN™ (vancomycin injection, USP) in the US

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 9/4/2026

1. LULU
2. ZS
3. IOT
4. PATH
5. DOCU
6. ASAN
7. GWRE
8. CPB
9. PL
10. OXM

Go back to Hikma launches TYZAVAN™ (vancomycin injection, USP) in the US
Hikma Pharmaceuticals plc, London Sponsored ADR (AMEX: HKMPY) Delayed: 43.18 --0 (-0%)
Previous Close $43.18    52 Week High $76.47 
Open $43.18    52 Week Low $50.73 
Day High $43.18    P/E N/A 
Day Low $43.18    EPS $0.00 
Volume 84